Evidence map›Paper›PMID 35201589›Full record

ArticleArchives of pharmacal research2022

New phenalenone derivatives from the Hawaiian volcanic soil-associated fungus Penicillium herquei FT729 and their inhibitory effects on indoleamine 2,3-dioxygenase 1 (IDO1).

Jae Sik Yu, Se Yun Jeong, Chunshun Li, Taehoon Oh, Mincheol Kwon, Jong Seog Ahn, Sung-Kyun Ko, Yoon-Joo Ko, Shugeng Cao, Ki Hyun Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of pharmacal research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. (Plants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Deodeokaloid, a New Indole AlkaloidPlants (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Rice (Foods (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chaenomelin, a New Phenolic Glycoside, and Anti-Plants (Basel, Switzerland) · 2024
    Article
  12. 3‴-Plants (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Antiviral Effects of Secondary Metabolites fromPlants (Basel, Switzerland) · 2023
    Article
  15. 6-Pentyl-α-Pyrone fromAntioxidants (Basel, Switzerland) · 2023
    Article
  16. Phytochemical Investigation ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Laricitrin 3-Rutinoside fromAntioxidants (Basel, Switzerland) · 2023
    Article
  19. Nutrients · 2023
    Article
  20. Methoxyflavones from Black Ginger (Plants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jae Sik YuSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Se Yun JeongSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Chunshun LiDaniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, HI, 96720, USA.
Taehoon OhAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, 28116, Republic of Korea.
Mincheol KwonAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, 28116, Republic of Korea.
Jong Seog AhnAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, 28116, Republic of Korea.
Sung-Kyun KoAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, 28116, Republic of Korea.
Yoon-Joo KoLaboratory of Nuclear Magnetic Resonance, National Center for Inter-University Research Facilities (NCIRF), Seoul National University, Gwanak-gu, Seoul, 08826, Republic of Korea.
Shugeng CaoDaniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, HI, 96720, USA.
Ki Hyun KimSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea. khkim83@skku.edu.ORCID http://orcid.org/0000-0002-5285-9138

Funding

Korea Research Institute of Bioscience and Biotechnology KGM5292113National Research Foundation of Korea 2019R1A5A2027340National Research Foundation of Korea 2021R1A2C2007937
6 · The paper itself

Abstract

Phenalenone derivatives sourced from fungi are polyketides that have attracted significant interest because of their diverse chemical structures and potential bioactivities. As part of our ongoing quest to discover novel natural products with biological properties from diverse natural resources, three unreported phenalenone derivatives (1-3), named ent-12-methoxyisoherqueinone (1), (-)-scleroamide (2), and (+)-scleroamide (3), together with four known phenalenone derivatives, ent-atrovenetinone (4), isoherqueinone (5), herqueinone (6), and ent-peniciherquinone (7) were isolated from the Hawaiian soil fungus Penicillium herquei FT729, collected on the Big Island, Hawaii. Compounds 2 and 3 were enantiomers, which were separated using a chiral-phase HPLC column, which provided optically pure compounds 2 and 3. The structures of the novel compounds were established by extensive spectroscopic analyses, including 1D and 2D NMR and high-resolution ESIMS. Their absolute configurations were determined using quantum chemical electronic circular dichroism (ECD) calculations. The inhibitory activity of the isolated compounds (1-7) against indoleamine 2,3-dioxygenase 1 (IDO1) was assessed. Compounds 1, 5-7 inhibited IDO1, with IC

Indexed as

PenicilliumSoil MicrobiologyAntineoplastic AgentsHawaiiHumansIndoleamine-Pyrrole 2,3,-DioxygenaseInhibitory Concentration 50PhenalenesStructure-Activity RelationshipAntineoplastic AgentsIndoleamine-Pyrrole 2,3,-Dioxygenasephenalen-1-onePhenalenesECD calculationIndoleamine 2,3-dioxygenase 1Penicillium herquei FT729Phenalenone derivativeStructural elucidation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.